Document is current
Any future updates will be listed below
-
Authors
dela Cruz, Adriane M. http://orcid.org/0000-0002-2268-498X
Walker, Robrina
Pipes, Ronny
Wakhlu, Sidarth
Trivedi, Madhukar H.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04059016 at ClinicalTrials.govDocuments that mention this clinical trial
Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care
https://doi.org/10.1186/s13722-021-00222-0
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (UG1DA020024)
- License Information
-
More Information
Article History
Received: 23 June 2020
Accepted: 6 February 2021
First Online: 19 February 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AMD, RW, RP, and SW declare they have no competing interests. MHT has served as an adviser or consultant for Abbott Laboratories, Abdi Ibrahim, Akzo (Organon Pharmaceuticals), Alkermes, AstraZeneca, Axon Advisors, Bristol-Myers Squibb, Cephalon, Cerecor, CME Institute of Physicians, Concert Pharmaceuticals, Eli Lilly, Evotec, Fabre Kramer Pharmaceuticals, Forest Pharmaceuticals, GlaxoSmithKline, Janssen Global Services, Janssen Pharmaceutica Products, Johnson & Johnson PRD, Libby, Lundbeck, Meade Johnson, MedAvante, Medtronic, Merck, Mitsubishi Tanabe Pharma Development America, Naurex, Neuronetics, Otsuka Pharmaceuticals, Pamlab, ParkeDavis Pharmaceuticals, Pfizer, PgxHealth, Phoenix Marketing Solutions, Rexahn Pharmaceuticals, Ridge Diagnostics, Roche Products, Sepracor, Shire Development, Sierra, SK Life and Science, Sunovion, Takeda, Tal Medical/Puretech Venture, Targacept, Transcept, VantagePoint, Vivus, and Wyeth-Ayerst Laboratories; he has received grants or research support from the Agency for Healthcare Research and Quality, Cyberonics, NARSAD, NIDA, and NIMH.
